LIfT BioSciences

LIfT BioSciences

Lift Biosciences is a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

Valuation: €0.0

round
N/A

€0.0

round
investor

€0.0

round
*

£10.0m

Series A
Total Funding000k
More about LIfT BioSciences
Edit

LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo